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Summary We studied motor cortical thresholds (TIs) and cortical silent periods (SPs)
evoked by transcranial magnetic stimulation (TMS) in 110 epileptic patients. Sixty-two
had primary generalised, 48 had partial type seizures. Fifteen out 110 patients were
analysed both before and after anticonvulsant medication. Our aims were to evaluate
the TI levels and the duration of SPs in patients with epilepsy and to determine the
reliability of TMS in patients with epilepsy. There was no negative effect of TMS
on the clinical status and EEG ﬁndings in patients with epilepsy. TIs obtained from
patients with partial epilepsy were higher than those obtained from both controls
and primary epileptics. The duration of SP in patients with primary epileptics was
more prolonged than those obtained from controls. There was no correlation between
EEG lateralisation and both SP duration and TI values. In de novo patient group, SP
duration was signiﬁcantly prolonged after anticonvulsant medication. We concluded
that TMS is a reliable electrophysiological investigation in patients with epilepsy. The
analysis of SP duration may be an appropriate investigation in monitoring the effect
of anticonvulsant medication on the cortical inhibitory activity.
© 2003 BEA Trading Ltd. Published by Elsevier Ltd. All rights reserved.
Introduction
Transcranial magnetic stimulation (TMS) has been
rarely used in epilepsy because of the probabil-
ity the potential risk of inducing seizure. However,
there are many reports over the reliability of TMS in
patients with epilepsy. Most of them have concluded
that TMS is reliable electrophysiological technique
in patients with epilepsy.1—3 Additionally, TMS can
be used for the localisation of epileptic focus in
presurgical evaluation.4
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TMS have both excitatory and inhibitory effects
on the motor cortex. After the TMS, initially, we
can see the excitatory effects of TMS as a mus-
cle response (motor evoked potential–—MEP) after
the TMS. This excitatory response is followed by
a silence (absence of electromyographic activ-
ity) at stimulated muscle, lasted about at 150ms.
It’s generally agreed that cortical silent period
(SP) reﬂects the activity of intracortical inhibitory
interneurons.5 Whereas, cortical motor thresholds
(TIs) reﬂects excitatory activity of motor cortex.
The alterations of the TI have been demonstrated
previously in patients with epilepsy.6 In epilepsy,
the balance between cortical excitatory and in-
hibitory activities changes in favour of excitatory
activity. There are many types of seizures and
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different patterns of excitatory and inhibitory
neuronal events in epilepsy. Some animal mod-
els suggest that the cortical hyperexcitability is
the mainly responsible process in idiopathic gen-
eralised epilepsy.7 On the other hand, partially
epilepsies are more heterogen conditions. Some
nondemonstrable structural lesions and aberrant
neuronal connections may be responsible for an
epileptogenic irritation in partially epilepsies.7
Anticonvulsants can depress the excitability of
the motor cortex and motor pathways in epileptic
patients. It is supposed that TI is a useful electro-
physiological parameter as an index of the adequacy
of treatment in patients with epilepsy.8 Addition-
ally, SP may also be useful parameter to examine
the inﬂuence of anticonvulsant treatment. There-
fore, it is thought that TI and SP can be used as
complementary tests in evaluation of patients with
epilepsy.
In this study, our aim was to analyse the effects
of both epilepsy and anticonvulsant drugs on these
electrophysiological parameters. These electro-
physiological parameters can be reliable guide in
management of epilepsy treatment.
Materials and methods
We studied 110 epileptic patients (48 men, 62
women) aged 16—58 (mean 28.3± 10.6) and 35
normal volunteers aged 8—54 (mean 31.6± 8.9).
Mean disease duration was 12.6± 7.1 years (be-
tween 1 and 22). Before the electrophysiological
assessment, all of the patients were evaluated ac-
cording to their seizure type, seizure frequency
and drugs used for epilepsy. Forty-eight patients
were subclassiﬁed as partial epilepsy [19 (17.3%)
had complex partial epilepsy (CPE), 25 had CPE
with secondary generalisation and 4 had simple
partial seizures]. On the other hand, 62 patients
with primary generalised epilepsy were included
to the study. Fifty of them had primary generalised
tonic-clonic seizures, 12 had primary myoclonic
seizures. All patients had not experienced any
seizure for last 48 h.
We classiﬁed our patients into three groups ac-
cording to seizure frequency (disease severity).
Fifty-nine out of 110 patients with epilepsy who
have 1—12 seizures per month was classiﬁed as
ﬁrst group (refractory group). Second group (par-
tially controlled) includes 22 patients who have
1—3 seizures per year. Twenty-nine who have no
history about seizure for last year were classi-
ﬁed as third group (controlled group). For last
month, mean seizure frequency of all patients was
2.15± 2.0.1—12 All patients were prescribed an-
ticonvulsant medication. Thirty-eight out of 110
patients with epilepsy were used CBZ, 24 were
used VLP, 10 were used phenytoin, 11 were used
both CBZ and VLP, 10 were used three or more
anticonvulsants.
Fifteen out of 110 patients were newly diag-
nosed as epilepsy (nine had primary generalised
tonic-clonic, six had CPE). Their electrophysiologi-
cal assessment were accomplished both before and
about 4 weeks after than beginning of antiepilep-
tic treatment. These patients were prescribed CBZ
(10 patients) or VLP (5 patients) as anticonvulsant
treatment after TMS.
Neurological examination were normal in all pa-
tients. Patients who had any cerebral lesion on
their CT or MRI examination were excluded. Sub-
jects were informed about the study and their
written consents were recruited.
Electrophysiological assessment
All of the patients had initial EEG investigations that
had been recorded just before TMS. Ninety-ﬁve of
them had second EEG, recorded after from TMS to
evaluate any effect of TMS on EEG. San-ei A97 18
channelled EEG device was used.
During the TMS, subjects reclined a comfort-
able armchair. Magstim 200 magnetic stimulator
was used. Ninety-millimetre diameter circular coil
was used for magnetic stimulation. Maximal mag-
netic ﬁeld that made up by this coil was 2.0 T.
For recording, Toennies multiliner EMG device was
used. Frequency ﬁlters were between 10Hz and
2 kHz, ossiloscope sweep time was 100ms, gain
was adjusted according to the amplitude of muscle
response. Initially, motor threshold level was de-
termined for each hemisphere. Motor threshold in-
tensity was deﬁned as the lowest stimulus intensity
required to evoke at least three consistent muscle
response being at least 50V. Coil was located on
the vertex. For recordings, we used disc electrodes
and muscle responses were recorded from ﬁrst
dorsalis interossei muscle at both sides. With slight
contraction of thenar muscle, MEPs were recorded.
For silent period analysis, stimulus intensity was
adjusted as 1.5-fold of motor threshold intensity,
determined for the same muscle. Osiloscope sweep
time was 500ms, gain was 0.2—0.4mV and fre-
quency ﬁlters were between 10Hz and 2 kHz. At
least, ﬁve traces were recorded. The mean du-
ration of SP was analysed by averaging of these
potentials in every subject.
The electrophysiological evaluation of de novo
group (n = 15) was performed before and 4 weeks
after anticonvulsant medication.
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Statistical methods
To compare the data obtained from electrophysi-
ological investigations from patients and controls,
we used Mann—Whitney U-test. In de novo group,
to compare data, obtained from predrug and post-
drug electrophysiological investigations we used
Wilcoxon analysis. P values smaller than 0.05 were
accepted as statistical signiﬁcance.
Results
EEG analysis of 54 patients accepted as within the
normal limits. Twenty-two patients had epileptic
activity on the right hemisphere, 11 had epilep-
tic activity on the left side. On the other hand, 9
patients showed bilateral epileptic activity. Seven
patients showed slow wave activity on their EEG
investigations (three had theta activity on the right
side, four had theta activity on the left side). No
clinical seizure was encountered in our patients
just after TMS. The patients were followed up along
the 4 weeks after TMS for their seizure frequency.
For the last month, mean seizure frequency of all
patients with epilepsy was 2.15± 2.0. However,
after TMS, mean seizure frequency observed for 1
month was 2.3± 2.1. There was no statistical dif-
ference in seizure frequencies between after and
before TMS (P > 0.05).
TI intensities of all epileptic patients (50.2±
13.0%) was higher than those obtained from con-
trols (P: 0.3). The threshold intensity of patients
with primary epileptics (generalised tonic-clonic)
was 48.9± 10.0%. There was no signiﬁcantly differ-
ence in TIs between primary generalised epileptics
and controls (45.6± 6.7%) (P: 0.1). The thresh-
old intensity of patients with partial epilepsy
(56.2± 16.2%) was higher than that obtained from
controls and generalised epileptics (P: 0.01 and
0.02, respectively). On the other hand, the thresh-
old intensity of patients with primary myoclonic
epilepsy (41.4± 10.0%) was signiﬁcantly lower than
that obtained from controls and patients with par-
Table 1 Cortical threshold levels and SP durations of patients who have different types of epilepsy.
Threshold intensities (TI) (%) P SP duration P
Partial epilepsy 56.2 ± 16.2 0.01 127.4 ± 45.0 0.2
Generalised tonic-clonic 48.9 ± 10.0 0.1 134.8 ± 44.6 0.0008
Generalised myoclonic 41.4 ± 10.0 0.02 142.4 ± 46.2 0.0007
Total (mean) 50.2 ± 13.0 0.03 134.9 ± 45.4 0.01
Controls 45.6 ± 6.7 117.6 ± 25.9
tial epilepsy (P: 0.02 and 0.001). The patients who
prescribed PHT had higher threshold intensities
than those obtained from the patients who used
CBZ or VLP (P: 0.02 for both groups). Additionally,
threshold intensities of patients medicated three or
more anticonvulsants (polytherapy) (59.8± 11.3%)
was higher than that obtained from patients on
monotherapy (47.1± 10.1%) (P: 0.0001). Table 1
demonstrates the threshold intensities of patients
with epilepsy and controls.
The duration of the SP in patients with epilepsy
(134.0± 45.4ms) were more prolonged than
those obtained from controls (117.6± 26.2ms)
(P: 0.0006). SP durations of patients with partial
epilepsy (127.4± 45.0) was not showed signiﬁ-
cantly difference from controls (P: 0.2). However,
the SP durations of patients with primary gener-
alised epileptics (134.8± 44.6) and primary my-
oclonic epilepsy (142.4± 46.2) was prolonged (P:
0.0008 and 0.0007, respectively). Table 1 shows
cortical threshold intensities and SP durations for
patients who have different types of epilepsy. The
duration of SP was not changed by the number of
drugs taken.
There was no signiﬁcant effect of epileptic focus
on SP duration or cortical motor threshold inten-
sity. The SP durations of non-epileptic and epileptic
hemisphere were 136.6± 44.5 and 131.4± 42.4,
respectively. Threshold intensities were also not
changed between epileptic (49.9± 11.6) and non-
epileptic side (50.6± 12.0) on EEG (P > 0.05).
TI levels of de novo patients (n = 15) were
48.8± 10.7% before anticonvulsant medication and
50.3± 9.0% 4 weeks after anticonvulsant medica-
tion. There was no statistical signiﬁcantly differ-
ence between pre and posttreatment TMS threshold
intensities (P: 0.2). Their initial SP durations was
122.0± 35.5ms. SP durations (150.4± 37.3ms),
obtained after the anticonvulsant treatment was
signiﬁcantly prolonged (P: 0.007) (Table 2). De
novo patients were used CBZ after initial TMS as
anticonvulsant therapy.
Disease severity did not affect the duration
of SP (Table 3). However, TI level obtained from
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Table 2 Predrug and postdrug SP durations of newly
diagnosed epileptic patients.
SP durations
(ms)
TI (%)
Initial investigation
(before medication)
133.6 ± 50.6 48.8 ± 10.7
Second investigation
(after medication)
152.0 ± 43.4 50.3 ± 9.0
P value 0.04* 0.2
* Statistical signiﬁcant at 95% level.
controlled patients was lower than that obtained
from both refractory and partially controlled groups
(P: 0.0008 and 0.001, respectively). There was no
signiﬁcantly difference in TI level between refrac-
tory and partially controlled groups.
Discussion
Our results demonstrate that the prolongation of SP
was observed in patients with primary epilepsy and
TI was higher in patients with partial epilepsy than
controls and patients with primary epilepsy. The ex-
citability of both excitatory and inhibitory cortical
neurons were increased in patients with myoclonic
epilepsy as contrast to other epileptic conditions.
The lateralisation of epileptic focus analysed by EEG
had no signiﬁcant effect on these electrophysiolog-
ical parameters. On the other hand, although anti-
convulsant medication had no effect on TI, the du-
ration of SP was signiﬁcantly prolonged after begin-
ning of anticonvulsant medication.
Initially, we determined the reliability of TMS in
patients with epilepsy. Many reports have empha-
sised that the TMS is a reliable electrophysiologi-
cal tool in patients with epilepsy.1—3,9,10 TMS can
merely result an increase in seizure frequency in
epileptic patients who had any lesion located on
cerebral hemisphere.10,11 Hufnagel et al.9 applied
Table 3 TI levels and the duration of SPs obtained
from epilepsy patients classiﬁed according to seizure
frequency.
TI (%) SP duration (ms)
Refractory (n = 59) 52.9 ± 15.2 135.0 ± 49.2
Partially controlled
(n = 22)
49.7 ± 9.3 134.8 ± 40.1
Controlled (n = 29) 45.3 ± 8.9* 131.4 ± 41.5
* Statistically signiﬁcant at the 0.01 level (between
controlled and both refractory and partially controlled
groups).
the TMS in 53 patients with temporal lobe epilepsy.
Classen et al. observed an epileptic seizure after
TMS in a patient who have a clear focus in left sup-
plementary motor area. In this patient TMS were
applied with 8 shaped coil. When they used circu-
lar coil for stimulation in same patient, any seizure
was not observed. They concluded that focal mag-
netic stimulation with 8 shaped coil results more
localised stimulation on motor cortex so the prob-
ability of seizure generation is higher than that of
stimulation with circular coil.12 Our results also in-
dicates that TMS does not cause increased seizure
frequency and EEG abnormalities for a period along
the 4 weeks.
In the present study, TI level was increased in only
patients with partial epilepsy. Additionally, the pa-
tients who used three or more anticonvulsant med-
ication had signiﬁcantly higher TI than patients on
fewer anticonvulsant therapy. On the other hand,
anticonvulsant medication has not increased TI lev-
els in de novo epileptic patients. It seems that an-
ticonvulsant medication with monotherapy did not
exert the level of TI, although, experimental ev-
idences suggest that anticonvulsant drugs depress
the excitability of cortical neurons.13 Individual an-
ticonvulsant drugs have different mechanisms of
action and electrophysiological effects.14,15 Never-
theless, the drug chosen for anticonvulsant medi-
cation had no effect of the level of TI. Some studies
have also demonstrated the increased levels of TI in
patients with partially epilepsy.6,9 Hufnagel et al.
observed that TI levels was decreased after anti-
convulsant medication was reduced.9 Reutens et al.
demonstrated that TI level was increased after anti-
convulsant therapy and TI was positively correlated
with anticonvulsant blood level in patients with id-
iopathic generalised epilepsy.8 Increased TI level
may represent protective mechanism due to anti-
convulsant drugs against the recurrence of seizures.
Nevertheless, our results suggest that the determi-
nation of TI levels is not a useful electrophysiologi-
cal tool for monitoring of the treatment in epilepsy.
In our study, although the duration of SP was
prolonged in patients with primary generalised
epilepsy, TI was not changed in these patients. This
ﬁnding has been observed previously.16 The dura-
tion of SP was also prolonged in patients with my-
oclonic epilepsy. Our ﬁndings may suggest that the
excitability of cortical inhibitory neurons were also
increased as well as excitatory neurons inmyoclonic
epilepsy. There is a discrepancy between our ﬁnd-
ing and literature. Manganotti et al. documented
impaired functioning of inhibitory interneuronal
circuits.17 Inghilleri et al. has also observed the
existence of impaired inhibition of motor cortex
in cortical myoclonus.18 This discrepancy can be
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explained by the effect of anticonvulsant medica-
tion on the duration of SP.
SP durations was not showed signiﬁcantly differ-
ence in patients with partial epilepsy. Macdonell
et al. demonstrated the prolonged SP duration in
patients with generalised epilepsy.19 There are
some evidences suggesting enhancement of both
excitatory and inhibitory neuronal activities in
epilepsy.20 These ﬁndings suggest that SP analysis
may be useful in evaluation of cortical excitatory
and inhibitory inﬂuences in generalised epilepsy.
It seems that prolonged duration of SP in patients
with primary generalised epilepsy may be caused
from enhanced intracortical inhibition.
On the other hand, anticonvulsant medication
had more profound effect on SP than TI in our de
novo group. Our de novo group was contained a
mixed patient population (primary generalised and
partial epileptic). This was the limitation of our
study. Therefore, this study can be performed in
more extensive patient population who have elec-
trophysiological investigations before and after an-
ticonvulsant medication. This analysis can permit
the effects of different anticonvulsant drugs on SP
and TI.
The lateralisation of epileptic abnormalities on
EEG had no effect on the duration of SP and TIs.
Similar result has been observed previously.9 The
duration of SP and TI levels were not compared
with blood concentrations of anticonvulsant drugs
in present study.
Clinical severity of epilepsy had no signiﬁcant ef-
fect on the duration of SP. Ertas et al. observed
that the duration of SP was prolonged in resistant
epileptics.21 Clinical severity had effect on the TI
level. TI levels can be inﬂuenced by the number of
anticonvulsant drugs taken due to resistant epilep-
tic seizures. Therefore, we believe that SP dura-
tions and TI levels are not reliable indicators of dis-
ease severity in epilepsy.
In conclusion, our results suggest that anticonvul-
sant medication cause different electrophysiolog-
ical characteristics in patients with epilepsy. The
prolongation of SP duration was observed in primary
generalised epileptics. On the other hand, TI level
was increased in patients with partial epilepsy. Ad-
ditionally, SP may be more useful electrophysiolog-
ical parameter than motor cortical TI in expressing
the effect of anticonvulsant medication in epilepsy.
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